6505--Clonidine Patches
ID: 36E79725R0037Type: Solicitation
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OFNAC PHARMACEUTICALS (36E797)HINES, IL, 60141, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/opp/4dd2f711af6e4014892e1d63bbc4597b/view
Timeline
    Description

    The Department of Veterans Affairs is seeking proposals for the procurement of clonidine patches, a pharmaceutical product essential for managing hypertension and attention deficit hyperactivity disorder (ADHD) in patients. Offerors are required to submit pricing for both base and option years, comply with federal regulations such as the Drug Supply Chain Security Act (DSCSA), and provide necessary compliance documentation, including Letters of Commitment from manufacturers. This solicitation emphasizes the importance of maintaining a consistent pharmaceutical supply for VA and Department of Defense healthcare, ensuring quality and traceability in the procurement process. The submission deadline for bids has been extended to June 10, 2025, at 2:30 PM CDT, and interested parties should acknowledge receipt of the amendment in their proposals. For further inquiries, contact Christopher Carthron at Christopher.Carthron@va.gov.

    Point(s) of Contact
    Christopher CarthronContract Specialist
    Christopher.Carthron@va.gov
    Files
    Title
    Posted
    36E79725R0037_1.docx
    The VA National Acquisition Center is preparing to issue Request for Proposal (RFP) 36E79725R0037 for the procurement of Clonidine Patches, which will be utilized by the Department of Veterans Affairs (VA), among other federal agencies. The contract, aimed at ensuring a reliable supply, will be granted to one responsible offeror for a one-year term with potential extensions. Offerors must provide their product's name and a unique National Drug Code (NDC), ensuring that only their label is affixed. The solicitation will be released electronically around May 13, 2025, with submissions closing by May 27, 2025. The NAICS code for this procurement is 325412, and all amendments will be available for download at sam.gov. Interested parties are encouraged to check the site for updates and can contact Christopher Carthron for inquiries. The estimated annual requirements include approximately 28,788 units of the 0.1 mg, 32,468 units of the 0.2 mg, and 36,204 units of the 0.3 mg Clonidine patches, emphasizing the significant demand for these products within the VA and associated federal health programs.
    36E79725R0037.docx
    The document outlines a solicitation from the Department of Veterans Affairs (VA) for pharmaceutical products, specifically clonidine patches, through a Request for Proposals (RFP). Key elements include the necessity for offerors to provide pricing for base and option years, compliance with federal regulations such as the Drug Supply Chain Security Act (DSCSA), and specific requirements for product labeling and manufacturing. The solicitation emphasizes awarding a single contract for the aggregate proposal based on National Drug Codes (NDCs) unique to each offering company and mandates submission of various compliance documents, including Letters of Commitment from manufacturers for non-manufacturers. An implementation period followed by a one-year ordering period and four optional extension periods is stipulated, with explicit instructions regarding order fulfillment and backorders. The document also includes detailed reporting and invoicing protocols, prioritizing traceability, quality standards, and compliance with FDA guidelines. Overall, the solicitation aims to ensure consistent pharmaceutical supply at committed pricing for VA and Department of Defense healthcare. This procurement process reflects governmental efforts to fortify healthcare delivery through efficient contract management and oversight.
    36E79725R0037 0001.docx
    This government document serves as an amendment to solicitation #36E79725R0037 issued by the Department of Veterans Affairs, National Acquisition Center. The primary purpose of this amendment is to extend the submission deadline for bids on Clonidine Patches. The original due date of June 3, 2025, has been moved to June 10, 2025, at 2:30 PM Central Daylight Time (CDT). The amendment also emphasizes that all other terms and conditions of the solicitation remain unchanged and must be adhered to by all offerors and bidders. Offerors must acknowledge receipt of this amendment in their submissions to avoid rejection. The document is structured with identifying codes, important dates, and a detailed description of the changes. It aims to ensure clear communication regarding the extension, facilitating an orderly procurement process while maintaining compliance with regulations governing federal solicitations. The document reaffirms the government’s commitment to transparency and responsiveness in the procurement process, allowing vendors extra time to prepare their proposals.
    36E79725R0037 0002.docx
    The document amends RFP 36E79725R0037 issued by the Department of Veterans Affairs, detailing updates necessary for contracting compliance. Essential modifications include extending the offer submission date and incorporating new clauses related to contractor responsibilities and prohibitions, such as the compliance with Executive Order 13899 and restrictions on telecommunication products from specific entities. The updated document outlines contract terms and conditions, ensuring adherence to federal statutes applicable to commercial products and services, with significant attention to small business considerations and anti-corruption measures. Emphasis is placed on contractor certifications regarding labor standards, lobbying disclosures, and the use of foreign end products, ensuring all participants comply with federal acquisition regulations. This amendment streamlines the procurement process for contractors looking to provide services or products to the federal government and reinforces accountability in contracting practices.
    Lifecycle
    Title
    Type
    6505--Clonidine Patches
    Currently viewing
    Solicitation
    6505--Clonidine Patches
    Presolicitation
    Similar Opportunities
    6505--Zonisamide Capsules
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified suppliers for a Firm Fixed Price, Indefinite-Delivery Requirements contract for Zonisamide Capsules in 25mg, 50mg, and 100mg dosages. Offerors are required to provide pricing for a base year and four option years, submit a 0.5% Cost Recovery Fee, and comply with stringent packaging and barcoding standards, including adherence to the Drug Supply Chain Security Act (DSCSA) and National Drug Code (NDC) requirements. These pharmaceutical products are crucial for the healthcare services provided to veterans and military personnel through the VA and DoD Pharmaceutical Prime Vendor Programs. Interested parties should contact Contract Specialist Christopher Carthron at Christopher.Carthron@va.gov for further details, and ensure they meet all compliance and registration requirements, including current SAM registration.
    COLESTIPOL HCL 1GM TAB and DESONIDE 0.05% CREAM - 762 TUCSON
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is conducting a Sources Sought Notice to identify potential qualified domestic sources for the procurement of COLESTIPOL HCL 1GM TAB and DESONIDE 0.05% CREAM through its National CMOP Office. This announcement serves as a market research tool rather than a solicitation, aiming to gather information on vendors' capabilities to meet the requirements outlined in the Statement of Requirements. The products sought are critical for pharmaceutical preparation and will support the healthcare needs of veterans. Interested vendors must submit their responses, including company details and capability statements, via email to Jennifer Coleman at Jennifer.Coleman4@va.gov by December 19, 2025, at 3:00 PM CDT. This notice does not obligate the VA to issue a solicitation.
    6505--Ustekinumab Pens/Syringes or Biosimilar
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Ustekinumab Pens/Syringes or Biosimilars, aimed at supplying various federal health entities including the Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. The contract will be awarded for an initial period of one year, with the possibility of four additional one-year option periods, ensuring a consistent supply of these critical pharmaceutical products through the VA and DoD Pharmaceutical Prime Vendor Programs. Offerors must provide drugs with unique National Drug Code (NDC) numbers and ensure that any biosimilar products meet FDA licensing requirements, as outlined in the FDA Purple Book. The solicitation is expected to be released around January 12, 2026, with a tentative closing date of January 27, 2026; interested parties should direct inquiries to Chris Carthron at Christopher.Carthron@va.gov or (708) 786-4980.
    6505--Nicotine Lozenges MINI (VA-26-00020754)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Nicotine Mini Lozenges, specifically under solicitation number 36E79726R0007. This contract aims to ensure an uninterrupted supply of nicotine lozenges for the VA, Department of Defense (DOD), Bureau of Prisons (BOP), and Indian Health Service (IHS), with a contract duration of one year and four optional one-year extensions. The estimated annual requirements include 166,791 bottles of 2mg lozenges and 138,276 bottles of 4mg lozenges, which will be distributed through the VA and DOD Pharmaceutical Prime Vendor Programs. Interested offerors should note that the solicitation will be electronically issued around December 18, 2025, with a tentative closing date of January 1, 2026, and can direct inquiries to Billy Fong at billy.fong@va.gov or by phone at 708-786-4992.
    760-25-1-050-0154 -Leavenworth CMOP THYROID TABLETS -(VA-25-00022614)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for the procurement of Armour Thyroid tablets for the Leavenworth Consolidated Mail Outpatient Pharmacy (CMOP) under solicitation number 36C77025Q0079. This Request for Quotation (RFQ) emphasizes the need for specific brand-name pharmaceuticals, with a focus on compliance with federal regulations, including the Drug Supply Chain Security Act and the Buy American Act. The procurement process aims to ensure a reliable supply of essential medications for veterans, with a firm-fixed-price contract expected to be awarded based on fair market evaluations. Interested vendors must submit their quotes by December 27, 2024, at 4:00 PM CST, and can direct inquiries to Jennifer L. Knight at jennifer.knight@va.gov or by phone at 913-684-0162.
    6505--36C77026Q0061/RFI/Domestic Sources Rx_MedSurge
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking information from domestic pharmaceutical manufacturers through a Request for Information (RFI) designated 36C77026Q0061, aimed at supporting the Consolidated Mail Outpatient Pharmacy (CMOP) in fulfilling its Open Market (OM) purchasing needs. The RFI seeks to identify both small and large businesses capable of providing a range of pharmaceutical products and ancillary items, with a focus on those manufactured in the United States, to enhance the supply chain for approximately 450,000 prescriptions mailed daily to Veterans. Interested manufacturers are required to submit detailed company and product information, including FDA-approved NDC numbers and operational capabilities, by March 15, 2026, at 4:30 PM CT. For further inquiries, respondents can contact Michael McAlhaney at Michael.McAlhaney@va.gov or (913) 684-1976.
    6515--Clitoral Therapy Device (CTD) (VA-24-00037945)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is soliciting proposals for the procurement of Clitoral Therapy Devices (CTD) and associated accessories under solicitation number 36C10G26Q0004. The objective of this procurement is to standardize products and reduce costs within the Veterans Health Administration (VHA), requiring FDA-approved devices that meet specific technical specifications, including removable cups, extension tubing, and a one-year warranty. These devices are critical for providing therapeutic support to veterans, ensuring they receive necessary medical care. Interested vendors should contact Contract Specialist Jessica L. Abrams at Jessica.Abrams@va.gov for further details, with proposals due by the specified deadline. The contract will be structured as an indefinite-quantity contract with a one-year base period and four one-year options, and contractors will be required to submit quarterly sales reports and pay a Service Level Agreement (SLA) fee.
    Dimethyl Fumarate DR Presolicitation
    Dept Of Defense
    The Defense Logistics Agency (DLA) is planning to issue a solicitation for a national requirements contract for Dimethyl Fumarate DR capsules, specifically 120MG capsules in 14 count bottles and 240MG capsules in 60 count bottles. This procurement aims to establish a reliable national supply source for these pharmaceutical products, which are essential for Department of Defense (DoD) customers through the DLA prime vendor program. The contract will be a firm-fixed price, requirements type contract with a one-year base period and four one-year options, emphasizing compliance with federal regulations and efficient distribution of pharmaceuticals for military healthcare. Interested parties should contact Kevin Rafferty at kevin.rafferty@dla.mil or 215-737-0907 for further inquiries, and the projected solicitation date is February 2021, with an amendment extending the offer submission deadline to October 14, 2021, at 3:00 PM EST.
    Sertraline Tablets
    Dept Of Defense
    The Department of Defense, through the Defense Logistics Agency (DLA) Troop Support, is soliciting offers for the procurement of Sertraline Tablets in 25MG, 50MG, and 100MG dosages, with various bottle counts required over a base year and four option years. This solicitation, identified as SPE2D2-26-R-0002, is critical for ensuring the availability of this essential pharmaceutical, which is commonly used to treat depression and anxiety disorders among military personnel. Interested contractors must submit their offers electronically via the Defense Logistics Agency Internet Bid Board System (DIBBS) by the extended deadline of December 17, 2025, at 3:00 PM EST, and are encouraged to contact Christopher Newman or Jason Wray for further inquiries regarding the solicitation.
    Trazodone - Solicitation
    Dept Of Defense
    The Department of Defense, through the Defense Logistics Agency (DLA) Troop Support, is soliciting offers for Trazodone HCL tablets in various dosages and bottle counts. This procurement aims to fulfill substantial pharmaceutical supply needs, emphasizing compliance with technical and quality requirements as outlined in the solicitation documents. The solicitation, identified as SPE2D2-26-R-0003, mandates electronic submissions via the Defense Logistics Agency Internet Bid Board System (DIBBS) by December 12, 2025, at 3:00 PM EST, with no alternative submission methods accepted. Interested parties can reach out to Nancy Fernandez at nancy.fernandez@dla.mil or Jason Wray at jason.wray@dla.mil for further inquiries.